Derek Stirewalt

Biography

Dr. Stirewalt earned his Bachelor's degree from Davidson College in 1988 and his M.D. from the University of North Carolina at Chapel Hill Medical School in 1992, where he also completed his internship and residency in internal medicine. He subsequently completed an Oncology Fellowship at the FHCRC/UW in 1999. After this fellowship, he was offered and accepted a faculty position at the FHCRC with a joint appointment at the UW. He has remained at the FHCRC since that time. Dr. Stirewalt currently holds an appointment as an associate professor at University of Washington and associate member at the Fred Hutchinson Cancer Research Center. Over his tenure at FHCRC and UW, he has become a very active member of the faculty – residing on or overseeing multiple committees such as IRB, FHCRC Clinical Division Appointments Committee, chair of the Nonmyeloablative Transplant Committee, and director of the FHCRC/UW Leukemia Repository.

Research Interest

Dr. Stirewalt’s research examines the biology of acute myeloid leukemia (AML) biomarkers and methods to use these biomarkers to improve the care of patients with this disease. This research has been funded through independent awards from NIH and other agencies. He is a nationally-recognized as a leader in the field of AML biomarker research, having extensive experience in the design, methods and analyses of quantitative RT/PCR assays, mutation studies, RNA profiling and novel RNA. His work has led to publications in Nature Cancer Review, Blood, and Leukemia on these topics, as well as, strong collaborations with other leaders in this field. In addition, he currently serves on several national committees or grant reviews such as Southwest Oncology Leukemia Committee and American Federation of Aging Research National Advisory Grant Review Group